Results 201 to 210 of about 159,909 (301)
Ileocecal Lipoma as a Lead Point for Adult Ileocolic Intussusception: A Diagnostic Challenge. [PDF]
Jha SK, Kafle S, Thakur AK.
europepmc +1 more source
ABSTRACT Catatonia occurs disproportionately in autistic individuals and may respond to electroconvulsive therapy (ECT), yet prior reports suggest greater treatment burden in this population. We compared longitudinal ECT utilization, safety, and clinical outcomes between autistic and non‐autistic patients with catatonia.
Joshua Ryan Smith +15 more
wiley +1 more source
Modified Primary PSARP for an Adult Patient With Imperforate Anus With Rectoperineal Fistula in a Low-Resource Setting: Case Report. [PDF]
Legesse AY +4 more
europepmc +1 more source
Aims Atypical colitis (presenting reverse gradient colitis, backwash ileitis or rectal sparing) is associated with primary sclerosing cholangitis–ulcerative colitis (PSC). Oral vancomycin has been used to manage paediatric atypical colitis with/without confirmed PSC. Different preparations had shown different efficacy.
Laura Räisänen +4 more
wiley +1 more source
Extended abstract presented at the CRIS2024 conference in Vienna.-- Event programme available at https://cris2024.eurocris.org/#programme25 slides.-- Presentation delivered within Session 2.2 "Persistent identifiers and knowledge graphs (I)" on
Gumpenberger, Christian +1 more
core
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source
Efficacy and tolerability of janus kinase inhibition strategies for moderate-to-severe Crohn's disease: A systematic review and bayesian network meta-analysis. [PDF]
Wazir HU +10 more
europepmc +1 more source
Aims The Black Triangle Scheme, introduced in 2018 in Australia, does not appear to have increased the quantity of adverse drug event (ADE) reports. This study evaluated healthcare professionals' (HCPs') and consumers' awareness of the scheme, its influence on intentions for future ADE reporting, and suggested improvements.
Eyob Alemayehu Gebreyohannes +7 more
wiley +1 more source

